Bird Rock Bio Investors

33 investors on Angel Roster list Bird Rock Bio in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and the Netherlands.

Investors are matched on the company name in their portfolio, so companies that share the name Bird Rock Bio can appear together.

Investors listed
33
With verified email
45%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 33 Bird Rock Bio investors

The most complete profiles first. Showing 33 of 33.

  • Andy SchwabVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more

    Verified email available

  • Brian DanielsVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Deborah PalestrantVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jason RuthVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Lou TartagliaVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Verified email available

  • Noga YerushalmiVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Owen LozmanVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Rebecca ChenVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Claudia ZimmermannVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • David PorterVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Verified email available

  • Elliot EhrichVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Javier RodriguezVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • Jonathan WeissmanVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Matthew FoyVerified

    Corporate Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more

    Verified email available

  • Paul StoneVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Sam GrayVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Verified email available

  • Cheryl Zimberlin

    Venture Capital, Corporate Venture Capital, Investor · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Christian Patze

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    SeedHealth CareDeepTechConsumer GoodsInfrastructure

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Jamil M. Beg

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • John Diekman

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Mason Freeman

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsGeneticsLife Science

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Mira Chaurushiya

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsAlternative MedicineAndroid

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Roel Bulthuis

    Venture Capital, Investor · Netherlands

    SeedAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Sapiens Steering Brain Stimulation, Salvia BioElectronics, Quantum Motion Technologies, Happeo and 42 more

    Contact details available

  • Scott Rocklage

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Alexander Cunynghame

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Anne

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Joseph Victor

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Julian Schubert

    Venture Capital, Corporate Venture Capital · Germany

    Health CareConsumer GoodsInfrastructureChemical

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Peter Kim

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Rory Pope

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsInvestment ManagementLife Science

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Steve Adkin

    Venture Capital · United Kingdom

    Health CareHospitalsLife ScienceSoftware

    Portfolio: Convergence Pharmaceuticals, Ulthera, Serentis, NIMGenetics and 8 more

    Contact details available

  • Wallace Wallace

    Venture Capital, Corporate Venture Capital · Netherlands

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

Frequently asked questions

How many Bird Rock Bio investors are on Angel Roster?

Angel Roster lists 33 Bird Rock Bio investors. 15 of them (45%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (32), Private Equity Firms (18) and Corporate Venture Capital Firms (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Bird Rock Bio investors invest in?

Among those that list a stage, the most common are Seed (16).

Where are Bird Rock Bio investors based?

Most are based in the United States (16), the United Kingdom (7) and the Netherlands (4).

Which companies have Bird Rock Bio investors backed?

The most-backed portfolio companies among them are Bellerophon Therapeutics (18), Igenica (16), IDEAYA Biosciences (16), Relypsa (16) and Vor Biopharma (16).

How do I contact Bird Rock Bio investors?

Create a free Angel Roster account to search and filter all 33, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.